Pre Tax Income - Ryvu Therapeutics SA (WSE:RVU) - Alpha Spread
R

Ryvu Therapeutics SA
WSE:RVU

Watchlist Manager
Ryvu Therapeutics SA
WSE:RVU
Watchlist
Price: 54.2 PLN -0.18% Market Closed
Market Cap: 1.3B PLN
Have any thoughts about
Ryvu Therapeutics SA?
Write Note

Ryvu Therapeutics SA
Pre-Tax Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Ryvu Therapeutics SA
Pre-Tax Income Peer Comparison

Comparables:
I
IGN
M
MDB
S
SLV

Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors

Company Pre-Tax Income CAGR 3Y CAGR 5Y CAGR 10Y
R
Ryvu Therapeutics SA
WSE:RVU
Pre-Tax Income
-zł93.9m
CAGR 3-Years
-33%
CAGR 5-Years
-62%
CAGR 10-Years
N/A
I
Inno-Gene SA
WSE:IGN
Pre-Tax Income
-zł5.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-18%
M
Medicofarma Biotech SA
WSE:MDB
Pre-Tax Income
-zł2.7m
CAGR 3-Years
-44%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Selvita SA
WSE:SLV
Pre-Tax Income
zł61.1m
CAGR 3-Years
37%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Ryvu Therapeutics SA's Pre-Tax Income?
Pre-Tax Income
-93.9m PLN

Based on the financial report for Mar 31, 2024, Ryvu Therapeutics SA's Pre-Tax Income amounts to -93.9m PLN.

What is Ryvu Therapeutics SA's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 5Y
-62%

Over the last year, the Pre-Tax Income growth was 3%. The average annual Pre-Tax Income growth rates for Ryvu Therapeutics SA have been -33% over the past three years , -62% over the past five years .

Back to Top